Advanced Oncotherapy (LON:AVO) Share Price Breaks Below 200 Day Moving Average – What’s Next?

Advanced Oncotherapy plc (LON:AVO – Get Your Free Report ) share price moved below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as high as GBX 1.75 ($0.02). Shares of Advanced Oncotherapy last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.

Price performance of advanced oncology

The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13, and a current ratio of 1.26. The stock has a market cap of £9.50 million, a price-to-earnings ratio of -25.00 and a beta of 0.06. The company’s 50-day moving average is GBX 1.75 and its 200-day moving average is GBX 1.75.

About Advanced Oncotherapy

(Get a free report)

Advanced Oncotherapy plc, together with its subsidiaries, engages in the design, assembly and sale of proton radiation therapy systems for the treatment of cancer. She is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in healthcare property management.

Further reading

Receive daily news and reviews for advanced oncology – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Advanced Oncology and related companies with MarketBeat.com’s FREE daily email newsletter.